Ultrasensitive acoustic reporter proteins with engineered rupture-resistant shells
Project Number5R21EB033607-03
Contact PI/Project LeaderLU, GEORGE J
Awardee OrganizationRICE UNIVERSITY
Description
Abstract Text
Project Summary / Abstract
The ability to image specific gene expression and cellular signaling pathways has long been a powerful tool for
scientists, and the methods to achieve this goal, such as the fluorescent reporter genes, are widely used
nowadays across different fields of biomedicine. However, the penetration depth of light has limited the use of
fluorescent reporter genes in animal models and cell-based therapies in humans. To this end. a group of gas-
filled protein nanostructures named gas vesicles (GVs) were recently introduced as the acoustic reporter genes
and enabled, for the first time, the use of ultrasound imaging to visualize specific gene expression in cells located
at centimeter-deep tissue. GVs are sub-micron particles originally evolved in photosynthetic microbes to achieve
cellular flotation, and expectedly, these wildtype GVs do not possess the correct properties that can maximize
their detection by ultrasound. This limitation on imaging sensitivity is perhaps the biggest hurdle currently facing
the application of the first-generation acoustic reporter genes. In this proposal, we aim to introduce the second-
generation acoustic reporter genes by innovating the mechanical properties of the protein shell. In Aim 1, we will
leverage the Genetic Code Expansion technology to achieve site-specific crosslinking among the monomeric
shell proteins. This is to recognize that the inward buckling of the protein shell holds the key to the sensitive
detection of these acoustic protein nanostructures but often leads to the rupture of the wildtype GV shell, and a
systematic crosslinking will substantially increase the tensile strength of these protein shells. Specifically, we will
systematically search sites that allow the incorporation of non-canonical amino acid and lysine for proximity-
induced chemistry, and this search will be performed under the rational guidance of the structural models. In
parallel to Aim 1, we will develop finite-element modeling and acoustic measurement method in Aim 2 to
understand the effect of crosslinking on the mechanical properties of the shell, which will establish benchmark
values and aims for the design of the protein nanostructures. In Aim 3, we seek to establish sensitivity
enhancement of these rupture-resistant acoustic protein nanostructures in a rodent model. Our interdisciplinary
approach merges synthetic biology, chemical biology, acoustics, and solid mechanics, and if successful, this
high-risk high-gain project will lead to a new generation of ultrasensitive acoustic reporter genes that broaden
the technology to many therapeutic and diagnostic applications, especially in the functional tracking of cell-based
therapies and targeted imaging of biomarkers.
Public Health Relevance Statement
Project Narrative
Imaging specific biological processes in cells is a fundamental capability for researchers and clinicians in the
disease diagnosis and monitoring of therapeutic cells. This proposal builds on the recently introduced ultrasound-
based reporter genes and aims to innovate the mechanical properties of these proteins to achieve substantially
higher imaging sensitivity. The utility of these newly designed proteins will be tested in vitro and in rodent models.
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
050299031
UEI
K51LECU1G8N3
Project Start Date
17-August-2022
Project End Date
30-April-2026
Budget Start Date
01-May-2024
Budget End Date
30-April-2026
Project Funding Information for 2024
Total Funding
$189,915
Direct Costs
$125,000
Indirect Costs
$64,915
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Biomedical Imaging and Bioengineering
$189,915
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R21EB033607-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R21EB033607-03
Patents
No Patents information available for 5R21EB033607-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R21EB033607-03
Clinical Studies
No Clinical Studies information available for 5R21EB033607-03
News and More
Related News Releases
No news release information available for 5R21EB033607-03
History
No Historical information available for 5R21EB033607-03
Similar Projects
No Similar Projects information available for 5R21EB033607-03